CLINICAL PHARMACOLOGY OF INFECTIOUS AND INFLAMMATORY DRUGS

Abstract

This article examines the clinical pharmacology of drugs used to manage infectious and inflammatory disorders, with emphasis on their mechanisms of action, pharmacokinetics, therapeutic applications, resistance patterns, safety considerations, and patient-specific factors influencing drug selection. The analysis integrates contemporary global guidelines and real clinical evidence, exploring how antimicrobial stewardship, immunomodulation, and inflammation-targeting therapies intersect in clinical decision-making. It also highlights the importance of personalized medicine, comorbidity-based drug selection, and the rising role of biomarker-guided therapy in optimizing outcomes for infectious and inflammatory diseases.